Netarsudil ophthalmic solution 0.02?

Netarsudil ophthalmic solution (0.02 %)
— marketed under the brand name Rhopressa (and a few generics).

What it is

Netarsudil is a Rho‑kinase (ROCK) inhibitor. By blocking ROCK in the eye, it improves the drainage of aqueous humor through the trabecular meshwork and Schlemm’s canal, thereby lowering intra‑ocular pressure (IOP).

Indication

• Primary open‑angle glaucoma (POAG) or ocular hypertension (OHT) in adults.
• Often used as an add‑on to other IOP‑lowering agents when the target pressure hasn’t been achieved.

How to use it

• Frequency: Twice daily (morning and evening).
• Duration: Usually continuous therapy; no fixed “course” length.

Key benefits

• Rapid IOP reduction (≈10‑12 % on average).
• Works independently of prostaglandin pathways, so it’s useful when other drugs (e.g., latanoprost, timolol) are insufficient.

Common side effects

Serious but uncommon events

• Corneal or ocular surface changes (e.g., epithelial micro‑defects).
• Systemic hypotension or tachycardia if large amounts are absorbed systemically (rare with proper technique).

Contraindications / Warnings

• Hypersensitivity to netarsudil or any excipient.
• Active ocular infections (e.g., severe conjunctivitis, keratitis).
• Pregnancy/Lactation: Limited data; use only if benefits outweigh risks.
• Corneal disease: Use cautiously; ophthalmic exam is recommended before initiation.

Drug interactions

• Other IOP‑lowering drops (e.g., timolol, latanoprost): additive effect but watch for excessive redness or irritation.
• Topical NSAIDs: May increase irritation.
• Systemic medications: Minimal systemic absorption, so interactions are unlikely.

Storage

• Keep in the refrigerator (2–8 °C) after first use.
• If left at room temperature for >24 h, discard.
• Do not freeze.
• Keep away from children; keep in original container.

Patient counseling points

• Apply correctly to avoid systemic absorption and eye irritation.
• Use as prescribed—don’t skip doses without consulting your provider.
• Report persistent redness, pain, vision changes, or new eye discharge.
• Schedule follow‑ups to monitor IOP and ocular health.

Bottom line

Netarsudil 0.02 % ophthalmic solution is a handy second‑line agent for lowering eye pressure when prostaglandins or beta‑blockers alone don’t do the job. It’s generally well‑tolerated, but watch for redness and irritation, and use it as directed by your eye care professional. If you have any concerns—especially about systemic side effects or interactions—talk to your clinician.